Cutler Group LP Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$171.37 - $283.23 $1.11 Million - $1.84 Million	6,500 Added 25.49%	32,000 $763,000
Q4 2023 Jan 18, 2024	SELL	$120.4 - $237.13 $927,080 - $1.83 Million	-7,700 Reduced 23.19%	25,500 $1.15 Million
Q3 2023 Nov 07, 2023	SELL	$146.04 - $225.78 $1.78 Million - $2.75 Million	-12,200 Reduced 26.87%	33,200 $2.6 Million
Q2 2023 Jul 18, 2023	BUY	$203.88 - $312.0 $6.63 Million - $10.1 Million	32,500 Added 251.94%	45,400 $1.73 Million
Q1 2023 May 01, 2023	SELL	$231.06 - $307.08 $2.15 Million - $2.86 Million	-9,300 Reduced 41.89%	12,900 $360,000
Q4 2022 Feb 07, 2023	BUY	$58.39 - $296.54 $1.11 Million - $5.63 Million	19,000 Added 593.75%	22,200 $207,000
Q3 2022 Oct 25, 2022	SELL	$60.57 - $79.51 $139,311 - $182,873	-2,300 Reduced 41.82%	3,200 $68,000
Q2 2022 Aug 04, 2022	SELL	$58.04 - $100.2 $29,020 - $50,100	-500 Reduced 8.33%	5,500 $72,000
Q1 2022 Apr 14, 2022	BUY	$55.89 - $101.89 $268,272 - $489,072	4,800 Added 400.0%	6,000 $17,000
Q4 2021 Jan 18, 2022	BUY	$72.34 - $95.09 $7,234 - $9,509	100 Added 9.09%	1,200 $4,000
Q3 2021 Oct 26, 2021	BUY	$78.35 - $105.02 $78,350 - $105,020	1,000 Added 1000.0%	1,100 $16,000
Q4 2020 Jan 21, 2021	SELL	$110.06 - $133.7 $550,300 - $668,500	-5,000 Reduced 98.04%	100 $1,000
Q3 2020 Oct 27, 2020	BUY	$99.78 - $124.21 $239,472 - $298,104	2,400 Added 88.89%	5,100 $4,000
Q2 2020 Jul 22, 2020	BUY	$60.13 - $125.71 $12,026 - $25,142	200 Added 8.0%	2,700 $4,000
Q1 2020 May 07, 2020	SELL	$66.76 - $93.49 $13,352 - $18,698	-200 Reduced 7.41%	2,500 $48,000
Q4 2019 Feb 06, 2020	BUY	$84.28 - $118.5 $42,140 - $59,250	500 Added 22.73%	2,700 $42,000
Q3 2019 Oct 28, 2019	SELL	$84.4 - $106.53 $573,920 - $724,404	-6,800 Reduced 75.56%	2,200 $81,000
Q2 2019 Aug 09, 2019	BUY	$91.13 - $142.5 $419,198 - $655,500	4,600 Added 104.55%	9,000 $84,000
Q1 2019 May 10, 2019	BUY	$103.48 - $143.84 $186,264 - $258,912	1,800 Added 69.23%	4,400 $107,000
Q4 2018 Feb 05, 2019	BUY	$94.77 - $215.54 $104,247 - $237,094	1,100 Added 73.33%	2,600 $138,000
Q3 2018 Nov 07, 2018	BUY	$207.3 - $300.31 $186,570 - $270,279	900 Added 150.0%	1,500 $47,000
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $60,930 - $188,340	600 New	600 $4,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$773 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$637 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$633 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$622 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$616 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account